← FDA DRUG APPROVALS

FDA NDA · NDA018256

DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINER

Sponsor: B BRAUN

APPLICATION
NDA018256
TYPE
NDA
ORIGINAL APPROVAL
1979-08-28
LATEST ACTION
1990-09-11
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

DEXTROSE 5% IN RINGER'S IN PLASTIC CONTAINERDiscontinued
CALCIUM CHLORIDE 33MG/100ML, DEXTROSE 5GM/100ML, POTASSIUM CHLORIDE 30MG/100ML, SODIUM CHLORIDE 860MG/100ML · INJECTABLE · INJECTION

Approval history

1990-09-11Manufacturing (CMC) · Supplement 13AP
1986-02-18Manufacturing (CMC) · Supplement 8AP
1985-06-28Manufacturing (CMC) · Supplement 9AP
1985-06-24Labeling · Supplement 11AP
1985-04-03Manufacturing (CMC) · Supplement 10AP
1983-01-24Labeling · Supplement 6AP
1981-10-26Manufacturing (CMC) · Supplement 7AP
1980-10-24Manufacturing (CMC) · Supplement 5AP
1980-08-06Manufacturing (CMC) · Supplement 4AP
1980-03-17Manufacturing (CMC) · Supplement 2AP
1980-02-19Labeling · Supplement 1AP
1980-02-12Manufacturing (CMC) · Supplement 3AP
1979-08-28OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →